Free Trial

RBC Life Sciences (RBCL) News Today

RBC Life Sciences logo
RBC Capital Sticks to Their Hold Rating for Wave Life Sciences (WVE)
Wave Life Sciences price target raised to $15 from $7 at RBC Capital
RBC Life Science and Technology (0P0001TAGA)
RBC Capital Reaffirms Their Hold Rating on BioMarin Pharmaceutical (BMRN)
RBC Capital Reaffirms Their Buy Rating on Edwards Lifesciences (EW)
RBC Mortgage Rates 2024
RBCL RBC Life Sciences, Inc.
RBC Capital Keeps Their Buy Rating on Illumina (ILMN)
PGA Tour Enterprises board meets at RBC Heritage
RBC Capital Sticks to Its Buy Rating for Telus (TU)
RBC Capital Reaffirms Their Buy Rating on Microsoft (MSFT)
HSBC to sell Canadian business to RBC for $10 bln
RBC Capital Keeps Their Buy Rating on Gilead Sciences (GILD)
Get RBC Life Sciences News Delivered to You Automatically

Sign up to receive the latest news and ratings for RBCL and its competitors with MarketBeat's FREE daily newsletter.

New Year, New Opportunity! 2 AI Stocks Under $10 Ready to Soar (Ad)

As we step into 2025, artificial intelligence (AI) stocks continue to dominate headlines, and now is the perfect moment to position yourself for the coming year’s potential. Our latest research has uncovered two must-buy AI stocks currently trading under $10/share – an affordable entry with promising growth potential. These stocks are flying under the radar, but it’s only a matter of time before they gain mainstream attention.

👉 Click here to access your FREE report now!

RBCL Media Mentions By Week

RBCL Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

RBCL
News Sentiment

0.00

0.47

Average
Medical
News Sentiment

RBCL News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

RBCL Articles
This Week

0

0

RBCL Articles
Average Week

Get RBC Life Sciences News Delivered to You Automatically

Sign up to receive the latest news and ratings for RBCL and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (OTCMKTS:RBCL) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners